These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1314 related items for PubMed ID: 26393772

  • 1. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
    Oh HJ, Ahn SV, Yoo DE, Kim SJ, Shin DH, Lee MJ, Kim HR, Park JT, Yoo TH, Kang SW, Choi KH, Han SH.
    Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
    [Abstract] [Full Text] [Related]

  • 4. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW.
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [Abstract] [Full Text] [Related]

  • 5. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
    Mallett A, Tang W, Hart G, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Clayton PA, Johnson DW.
    Am J Nephrol; 2015 Dec; 42(3):177-84. PubMed ID: 26418732
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Yang WL, Bose B, Zhang L, Mcstea M, Cho Y, Fahim M, Hawley CM, Pascoe EM, Johnson DW.
    PLoS One; 2019 Dec; 14(8):e0221531. PubMed ID: 31442267
    [Abstract] [Full Text] [Related]

  • 7. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
    Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC, González-Lamuño D, Mata C, Gortázar P, Rueda-Gotor J, Arias M, Peiró E, Martínez-Taboada VM, González-Gay MA, Blanco R.
    Clin Exp Rheumatol; 2013 Dec; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ, Cho Y, Teixiera-Pinto A, Isbel N, Campbell S, Hawley C, Johnson DW.
    BMC Nephrol; 2019 Nov 21; 20(1):417. PubMed ID: 31752734
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival of patients with IgA nephropathy after dialysis therapy.
    Komatsu H, Kikuchi M, Nakagawa H, Fukuda A, Iwakiri T, Toida T, Sato Y, Kitamura K, Fujimoto S.
    Kidney Blood Press Res; 2013 Nov 21; 37(6):649-56. PubMed ID: 24356555
    [Abstract] [Full Text] [Related]

  • 10. Patient characteristics and outcomes by GN subtype in ESRD.
    O'Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC.
    Clin J Am Soc Nephrol; 2015 Jul 07; 10(7):1170-8. PubMed ID: 26092830
    [Abstract] [Full Text] [Related]

  • 11. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
    Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, Peh CA, Johnson DW.
    Clin J Am Soc Nephrol; 2013 May 07; 8(5):773-80. PubMed ID: 23349331
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.
    Am J Kidney Dis; 2015 Oct 07; 66(4):613-20. PubMed ID: 25975963
    [Abstract] [Full Text] [Related]

  • 13. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
    Tang W, Mohandas J, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Wiggins KJ, Bannister KM, Campbell SB, Johnson DW.
    BMC Nephrol; 2012 Dec 03; 13():164. PubMed ID: 23206870
    [Abstract] [Full Text] [Related]

  • 14. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
    Webster AC, Irish AB, Kelly PJ.
    Nephrology (Carlton); 2018 Mar 03; 23(3):217-225. PubMed ID: 28004444
    [Abstract] [Full Text] [Related]

  • 15. Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysis.
    Kadiyala A, Mathew AT, Sachdeva M, Sison CP, Shah HH, Fishbane S, Jhaveri KD.
    Clin Transplant; 2015 Oct 03; 29(10):911-9. PubMed ID: 26190417
    [Abstract] [Full Text] [Related]

  • 16. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
    Tang W, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, de Zoysa JR, Johnson DW.
    Nephrol Dial Transplant; 2013 Feb 03; 28(2):455-61. PubMed ID: 23182810
    [Abstract] [Full Text] [Related]

  • 17. [REIN Report 2011--summary].
    Couchoud C, Lassalle M, Jacquelinet C.
    Nephrol Ther; 2013 Sep 03; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [Abstract] [Full Text] [Related]

  • 18. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H, Fujimoto S, Kikuchi M, Sato Y, Kitamura K.
    Ren Fail; 2012 Sep 03; 34(4):448-53. PubMed ID: 22260382
    [Abstract] [Full Text] [Related]

  • 19. Dialysis outcomes of elderly Indigenous and non-Indigenous Australians.
    McKercher C, Chan HW, Clayton PA, McDonald S, Jose MD.
    Nephrology (Carlton); 2014 Oct 03; 19(10):610-6. PubMed ID: 25066470
    [Abstract] [Full Text] [Related]

  • 20. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.
    Mao S, Xuan X, Sha Y, Zhao S, Zhu C, Zhang A, Huang S.
    Int J Clin Exp Pathol; 2015 Oct 03; 8(3):2334-42. PubMed ID: 26045740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.